Search results for "PULMONARY"

showing 10 items of 3030 documents

Treatment of heart failure with preserved ejection fraction.

2018

Heart failure, in its diverse forms based on the value of the ejection fraction, is associated to high mortality and the frequent need for hospitalization, with a consequent heavy burden on healthcare resources. For an appropriate treatment of heart failure with preserved ejection fraction (HFpEF), there are no specific drugs effective for this condition. Those indicated in HF with reduced EF (HFrEF) are of more benefit in that form of HF, according to the guidelines of the European Society of Cardiology of 2016: ACE-inhibitors, beta-blockers, anti-aldosterones are all indicated with a class of recommendation/level of evidence IA; therapy with loop diuretics is indicated in the case of clin…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyEjection fractionSettore MED/09 - Medicina Internalcsh:Medicineheart failuretherapeutic strategies.Hospitalization rateInternal medicineMedicineAerobic exerciseguidelinesEjection fraction; comorbidity; guidelines; heart failure; therapeutic strategies.Ejection fractionbusiness.industryHigh mortalitylcsh:REvidence-based medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolarecomorbidityHeart failureCardiologyCardiology and Cardiovascular MedicineHeart failure with preserved ejection fractionbusinessguidelineMonaldi archives for chest disease = Archivio Monaldi per le malattie del torace
researchProduct

Incidence and Clinical Impact of Right Ventricular Involvement (Biventricular Ballooning) in Takotsubo Syndrome

2021

Background The short- and long-term prognosis of Takotsubo syndrome (TTS) presenting with right ventricular (RV) involvement remains poorly understood. Research Question What is the incidence and clinical outcome of RV involvement in TTS? Study Design and Methods This study analyzed 839 consecutive patients with TTS (758 female subjects and 81 male subjects) in a multicenter registry. RV involvement was defined as wall motion abnormality of the RV free wall, with or without apical involvement. The median long-term follow-up was 2.1 years (interquartile range, 0.3-4.5 years). The primary outcome was in-hospital and out-of-hospital all-cause mortality. The secondary end point was a composite …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyEjection fractionbusiness.industryCardiogenic shockIncidence (epidemiology)Hazard ratioCritical Care and Intensive Care Medicinemedicine.diseasePulmonary edemaClinical trial03 medical and health sciences0302 clinical medicine030228 respiratory systemInterquartile rangeInternal medicineCohortmedicineCardiology030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessChest
researchProduct

A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic.

2021

Objective: In this review, we evaluate the role of liquid biopsy in managing lung cancer patients during the still ongoing coronavirus disease 2019 (COVID-19) healthcare emergency. Background: The novel influenza coronavirus (severe acute respiratory syndrome coronavirus or SARSCoV-2) has upended several aspects of our lives, including medical activities. In this setting, many routine cancer diagnostic and therapeutic procedures have been suspended, leading to delays in diagnosis, treatments, and, ultimately, increases in cancer mortality rates. Equally drastic has been the impact of COVID-19 on clinical trials, many of which have been stalled or have never begun. This has left many patient…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Review Articlemedicine.disease_causePandemicHealth caremedicinecell-free DNA (cfDNA)Radiology Nuclear Medicine and imagingLiquid biopsythoracic tumorsIntensive care medicineLung cancerCoronavirusLiquid biopsybusiness.industrythoracic tumorMediastinumCancermedicine.diseasenonsmall cell lung cancer (NSCLC)Clinical trialnon-small cell lung cancer (NSCLC)medicine.anatomical_structureOncologycoronavirus disease 2019 (COVID-19)Cardiology and Cardiovascular MedicinebusinessMediastinum (Hong Kong, China)
researchProduct

Neutrophil Adherence to Activated Saphenous Vein and Mammary Endothelium After Graft Preparation

2005

Interaction of circulating leukocytes and vascular endothelium plays an important role in vasoconstriction, endothelial dysfunction, and vascular injury. Dilation procedures of grafts before coronary artery bypass graft surgery might lead to vascular injury and subsequent bypass graft disease.We analyzed in vitro the adherence of fluorescence-labeled polymorphonuclear neutrophils (PMNs) to endothelium of human saphenous vein grafts or internal mammary artery grafts after stimulation with thrombin (0.5 to 2 U/mL) or dilating procedures. Furthermore, we investigated endothelial function of prepared grafts.Thrombin stimulation resulted in a dose-dependent increase of PMN adherence to the endot…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyEndotheliumNeutrophilsVasodilator AgentsIn Vitro TechniquesAnastomosisGranulocyteThrombinPapaverineInternal medicinePreoperative CareCell AdhesionmedicineHumansSaphenous VeinCoronary Artery BypassMammary ArteriesEndothelial dysfunctionPapaverinebusiness.industryThrombinmedicine.diseaseDilatationSurgerymedicine.anatomical_structureCardiologySurgeryEndothelium Vascularmedicine.symptomCardiology and Cardiovascular MedicinebusinessVasoconstrictionmedicine.drugArteryThe Annals of Thoracic Surgery
researchProduct

Critical role of fractalkine (CX3CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium.

2012

Background Cigarette smoking is an important risk factor for the development of cardiovascular disease, yet the pathways through which this may operate are poorly understood. Therefore, the mechanism underlying cigarette smoke (CS)-induced arterial endothelial dysfunction and the potential link with fractalkine/CX3CL1 upregulation were investigated. Methods and results Stimulation of human arterial umbilical endothelial cells (HUAECs) with pathophysiological concentrations of CS extract (1% CSE) increased CX3CL1 expression. Neutralisation of CX3CL1 activity under dynamic flow conditions significantly inhibited CSE-induced mononuclear cell adhesion to HUAECs (67%). The use of small interferi…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyEndotheliumPeripheral blood mononuclear cellMiceInternal medicineCX3CR1Cell AdhesionMedicineAnimalsHumansEndothelial dysfunctionRNA Small InterferingCell adhesionNADPH oxidasebiologybusiness.industryChemokine CX3CL1MicrocirculationSmokingNOX4Membrane ProteinsNADPH Oxidasesmedicine.diseaseUp-RegulationEndothelial stem cellmedicine.anatomical_structureEndocrinologyNADPH Oxidase 5Immunologybiology.proteinEndothelium VascularbusinessThorax
researchProduct

Extracorporeal circulation activates endothelial nitric oxide synthase in erythrocytes.

2007

Background Extracorporeal circulation used in cardiopulmonary bypass and hemodialysis is often associated with severe hypotension, which is an important predictor for mortality and morbidity. One pathophysiological hypothesis includes nitric oxide (NO) generation. Recently, a functional NO synthase (endothelial type NO synthase [eNOS]), was found to be expressed in human red blood cells. However, to date, activation of red blood cell eNOS has not been shown. We hypothesized that eNOS in circulating red blood cells might be activated during extracorporeal circulation and thus contribute to hypotension through vasodilation upon NO release. Methods We collected blood samples from 28 patients e…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyErythrocytesEndotheliumNitric Oxide Synthase Type IIIVasodilationNitric Oxidelaw.inventionNitric oxidechemistry.chemical_compoundlawEnosInternal medicinemedicineCardiopulmonary bypassHumansCardiopulmonary Bypassbiologybusiness.industryExtracorporeal circulationbiology.organism_classificationNitric oxide synthaseEnzyme ActivationVasodilationRed blood cellEndocrinologymedicine.anatomical_structurechemistryAnesthesiabiology.proteinSurgeryHypotensionCardiology and Cardiovascular MedicinebusinessThe Annals of thoracic surgery
researchProduct

Risk and Complication Management in Esophageal Cancer Surgery: A Review of the Literature

2015

Esophagectomy for cancer is a highly complex and demanding two-cavity procedure associated with a considerable morbidity and mortality. There are several controversies with regard to the optimal risk and complication management. Strategies include patient selection, optimization of malnutrition, hospital and surgeon volume, intraoperative anesthesiological and surgical measures, and postoperative management of complications. In this article, we review the literature on these aspects that have an impact on outcomes after esophagectomy.

Pulmonary and Respiratory Medicinemedicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatmentMEDLINEPostoperative managementPostoperative ComplicationsRisk FactorsmedicineHumansIntensive care medicineSurgeon volumebusiness.industryGeneral surgeryCancerEsophageal cancermedicine.diseaseSurgeryEsophagectomyMalnutritionTreatment OutcomeEsophagectomySurgeryCardiology and Cardiovascular MedicinebusinessComplicationThe Thoracic and Cardiovascular Surgeon
researchProduct

Mild obstructive sleep apnea increases hypertension risk, challenging traditional severity classification

2020

STUDY OBJECTIVES: The association of mild obstructive sleep apnea (OSA) with important clinical outcomes remains unclear. We aimed to investigate the association between mild OSA and systemic arterial hypertension (SAH) in the European Sleep Apnea Database cohort. METHODS: In a multicenter sample of 4,732 participants, we analyzed the risk of mild OSA (subclassified into 2 groups: mild(AHI 5-<11/h) (apnea-hypopnea index [AHI], 5 to <11 events/h) and mild(AHI 11-<15/h) (AHI, ≥11 to <15 events/h) compared with nonapneic snorers for prevalent SAH after adjustment for relevant confounding factors including sex, age, smoking, obesity, daytime sleepiness, dyslipidemia, chronic obstructive pulmona…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyEuropean Sleep Apnea Database Mild obstructive sleep apnea Systemic arterial hypertensionPolysomnographyDisorders of Excessive SomnolenceSettore MED/10 - Malattie Dell'Apparato RespiratorioHypertension risk03 medical and health sciences0302 clinical medicinestomatognathic systemRisk FactorsInternal medicinesystemic arterial hypertensionmedicineHumansEuropean Sleep Apnea DatabaseSleep Apnea ObstructiveSystemic arterial hypertensionbusiness.industrymedicine.diseaseScientific InvestigationsClinical neurologyrespiratory tract diseasesnervous system diseasesObstructive sleep apneamild obstructive sleep apneaDiabetes Mellitus Type 2NeurologyHypertensionNeurology (clinical)Human medicinebusiness030217 neurology & neurosurgery
researchProduct

Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy

2017

Reslizumab, an anti-interleukin-5 monoclonal antibody, significantly reduces exacerbation frequency and improves lung function, asthma control and quality of life in adults with severe eosinophilic asthma, as demonstrated in Phase III studies. This secondary analysis assessed reslizumab's efficacy in patients receiving baseline treatment per Global Initiative for Asthma (GINA) Step 4 and Step 5 guidelines. Pooled data from duplicate, Phase III, reslizumab versus placebo studies in patients with severe eosinophilic asthma (blood eosinophils ≥400 cells·µL−1) were stratified by baseline therapy. Efficacy assessments were exacerbation rates and changes from baseline forced expiratory volume in …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyExacerbation2lcsh:MedicineEosinophilic asthmaPlacebo03 medical and health sciences0302 clinical medicineQuality of lifeReslizumabInternal medicineSecondary analysismedicineMedicine and Health Sciences030212 general & internal medicineLung functionAsthmabusiness.industrylcsh:ROriginal Articlesmedicine.diseaseSurgery030228 respiratory systembusinessmedicine.drugERJ Open Research
researchProduct

Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.

2005

Exacerbations are an important cause of the morbidity and mortality associated with asthma and chronic obstructive pulmonary disease. Newer therapies include long-acting beta(2)-agonists, which are more effective than short-acting bronchodilators. Inhaled corticosteroids and, in asthma, leukotriene receptor antagonists may have roles in the early phase of exacerbation as an alternative to or added to oral prednisolone. In the future, combinations of long-acting beta(2)-agonists and anticholinergic bronchodilators may offer additive clinical benefits. However, although the treatment and prevention of exacerbations of chronic obstructive pulmonary disease and asthma have been improved by usin…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyExacerbationPulmonary diseaseInhaled corticosteroidsPulmonary Disease Chronic ObstructivePharmacotherapyAdrenal Cortex HormonesmedicineHumansPharmacologic therapyAnti-Asthmatic AgentsIntensive care medicineAsthmabusiness.industryAdrenergic beta-Agonistsmedicine.diseaseAsthmaAnti-Bacterial AgentsBronchodilator AgentsDrug CombinationsEtiologyDisease ProgressionLeukotriene AntagonistsDrug Therapy CombinationEarly phasebusinessForecastingProceedings of the American Thoracic Society
researchProduct